03/18/2025
7:00 AM | Iterum Therapeutics (Issuer)
Whalen Joseph John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/10/2025
7:35 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
02/14/2025
4:36 PM | ARMISTICE CAPITAL, LLC (Filed by)
Iterum Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:33 PM | Iterum Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/07/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/23/2025
5:30 PM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
6:04 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ITRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
6:54 PM | Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:10 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:24 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
5:06 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/25/2024
10:20 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
7:00 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:20 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:15 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/30/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
7:59 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
8:01 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/23/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/11/2024
3:50 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/09/2024
5:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
08/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
08/12/2024
8:00 AM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:00 AM | Fishman Corey N. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:28 PM | Iterum Therapeutics (Filer)
| Form POS AM | |
08/06/2024
4:25 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
07/22/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
07/19/2024
4:05 PM | Iterum Therapeutics (Filer)
| Form 424B3 | |
07/17/2024
3:21 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad) We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America.
Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking.
And he believes Trump could soon release this frozen asset to the public.
 But something even more spectacular is bound to happen. And those who know what to expect could make |
06/26/2024
4:24 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
4:27 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
06/21/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:11 PM | Iterum Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/31/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:00 AM | Iterum Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ITRM Stock Free ITRM Stock Alerts